Clinical trials: Type 2 Asthma
Asthma, COPD (Chronic Obstructive Pulmonary Disease)
T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD
This prospective, real-world observational study (T2AIR Study) evaluates the long-term efficacy and safety of six biologics targeting Type 2 inflammation - omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab, and…
- Trial name
- T2AIR (NCT07823842)
- Testing
- Biologics targeting Type 2 inflammation, Patients with asthma and copd who received standard of care
- Where
- China
- Volunteers
- 538 people
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
Asthma, Diabetes Mellitus
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Asthma
- Trial name
- NCT00139659
- Testing
- Inhaled Insulin, Subcutaneous Insulin
- Where
- 102 sites in United States, Brazil and 3 more
- Volunteers
- 288 people
- Sponsor
- Pfizer
Arterial Hypertension, Atherosclerosis Occlusive Disease
Gut Microbiota in Chronic Noncommunicable Diseases
It is an observational study in patients with chronic noncommunicable diseases (i.e. cardiovascular diseases, diabetes mellitus, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease and asthma ) and control…
- Conditions
- Arterial Hypertension, Atherosclerosis Occlusive Disease, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction
- Trial name
- NCT04820556
- Where
- 2 sites in Russia
- Volunteers
- 1,084 people
- Sponsor
- National Medical Research Center for Therapy and Preventive Medicine
Cardiovascular Disease, Type 2 Diabetes
Health2010-14: Monitoring Biomarkers of Chronic Diseases in the General Population
The overall aim of the Health2010-14 is to monitor the prevalence and trends of common chronic diseases (osteoporosis, diabetes, cardiovascular disease, asthma, allergy, and eczema) that are often un-diagnosed in the general…
- Conditions
- Cardiovascular Disease, Type 2 Diabetes, Asthma, Allergy
- Trial name
- Health2010-4 (NCT01038518)
- Volunteers
- 1,522 people
- Sponsor
- Glostrup University Hospital, Copenhagen
Asthma, Chronic Rhinosinusitis With Nasal Polyps
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
Asthma and chronic rhinosinusitis (CRS) are inflammatory diseases of the respiratory tract, asthma from the lower part, and CRS, from the upper part.
- Conditions
- Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis), Nasal Polyps
- Trial name
- PREMIUM (NCT05009758)
- Testing
- Blood sampling, Nasosorption, Oral sampling
- Where
- Austria
- Volunteers
- 30 people
- Sponsor
- Medical University of Vienna
Seasonal Affective Rhinitis, Asthma
Seasonal Allergic Rhinitis Study
The study aims to examine the effect of probiotics on the clinical symptoms of allergic rhinitis and to elucidate some of the immunological mechanisms involved.
- Conditions
- Seasonal Affective Rhinitis, Asthma, Grass Allergy
- Trial name
- SAR (NCT01123252)
- Testing
- Lactobacillus casei Shirota (LcS)
- Where
- 4 sites in United Kingdom
- Volunteers
- 60 people
- Sponsor
- University of East Anglia
Cardiovascular Disease, Type 2 Diabetes
Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and Allergy
The aim is to assess the population prevalence of risk factors for different chronic diseases such as cardiovascular disease, type 2 diabetes, osteoporosis, asthma, and allergy.
- Conditions
- Cardiovascular Disease, Type 2 Diabetes, Asthma, Hypersensitivity
- Trial name
- NCT00316667
- Where
- Denmark
- Volunteers
- 3,471 people, healthy volunteers welcome
- Sponsor
- Glostrup University Hospital, Copenhagen
Asthma
Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)
This study is designed to demonstrate that formoterol 12µg and 24µg delivered by a new inhalation device (Concept1) are equivalent to the corresponding dose of formoterol delivered by the Aerolizer device in terms of efficacy, in…
- Trial name
- NCT00443482
- Testing
- formoterol
- Where
- 4 sites in Germany
- Volunteers
- 50 people
- Sponsor
- Novartis
Asthma
Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study
The primary objective of this study is to demonstrate differences in ILC2 blood levels between asthma patients and control patients.
- Trial name
- ILC2-Asthma (NCT03128762)
- Testing
- ILC2 levels in blood
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- University Hospital, Montpellier
Asthma, Chronic Obstructive Pulmonary Disease
Usability and Acceptability Study of the P-STEP Mobile Application
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
- Conditions
- Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Coronary Heart Disease
- Trial name
- NCT05830318
- Testing
- P-STEP Mobile Application
- Where
- United Kingdom
- Volunteers
- 178 people
- Sponsor
- University of Leicester